Succinylcholine Chloride Injection recall
FDA recall D-0008-2026 · initiated Sep 26, 2025
Dr. Reddy's Laboratories, Inc. recalled Succinylcholine Chloride Injection in Sep 2025 — an FDA Class II recall (D-0008-2026) because Out-of-Specification (OOS) result during the 6-month stability testing; decreased preservative concentration.
May cause temporary or medically reversible harm; low probability of serious harm.
Why it was recalled
Out-of-Specification (OOS) result during the 6-month stability testing; decreased preservative concentration.
Wrong strength, or it did not keep
The product did not contain what the label promised, or stopped meeting specification before its expiry date. Under-strength medicine can mean an untreated condition.
This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.
Is your product affected? Check the lot number
A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.
Quantity recalled: 571 vials
Details
- Product
- Succinylcholine Chloride Injection, USP, 200 mg/10 mL (20 mg/mL), 25 x 10 mL Multiple-Dose Vials, For Intravenous or Intramuscular use, Rx Only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540. NDC: 43598-666-25
- Recalling company
- Dr. Reddy's Laboratories Limited
- Classification
- Class II
- Status
- Ongoing
- Type
- Voluntary: Firm initiated
- Distribution
- Nationwide within the USA.
- Initiated
- Sep 26, 2025
- FDA report date
- Oct 15, 2025
Frequently asked
- Was Succinylcholine Chloride Injection recalled?
- Dr. Reddy's Laboratories, Inc. recalled Succinylcholine Chloride Injection in Sep 2025 — an FDA Class II recall (D-0008-2026) because Out-of-Specification (OOS) result during the 6-month stability testing; decreased preservative concentration. May cause temporary or medically reversible harm; low probability of serious harm.
- Why was Succinylcholine Chloride Injection recalled?
- Per the FDA enforcement record, the reason for recall D-0008-2026 was: Out-of-Specification (OOS) result during the 6-month stability testing; decreased preservative concentration.
- Is a recalled Succinylcholine Chloride Injection dangerous to take?
- An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
- Which lots of Succinylcholine Chloride Injection are affected?
- Distributed: Nationwide within the USA.. The recall covers these lots — Lot # K250048. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0008-2026.